Cell Proliferation Journal Citation Rate 2026

ISSN 0960-7722 eISSN 1365-2184 Wiley GB

Q1 Quartile Open Access Top Tier Fast Review Verified Publisher

About Cell Proliferation
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cell Proliferation (CP) is a peer-reviewed academic journal covering Cancer Cells and Metastasis and Mesenchymal stem cell research, published by Wiley in GB, catalogued under ISSN 0960-7722 (e-ISSN 1365-2184). As of 2026, it has a 2024 2-Year Citation Rate (OpenAlex) of 64.50 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access. OpenAlex records 5,031 works and 138,674 citations, with an h-index of 138.

Authors typically receive a first decision in around 43 days.

Cell Proliferation Citation Rate 2026 — In Context

Cell Proliferation has a 2024 2-Year Citation Rate (OpenAlex) of 64.50, placing it in the Q1 quartile within the Cancer Cells and Metastasis research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Cell Proliferation makes all articles freely available to readers. Average submission-to-decision turnaround is approximately 43 days — fast by sector standards.

Researchers looking to publish in Cell Proliferation should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cell Proliferation against similar journals in the field, use our journal comparison tool.

Submission Tips for Cell Proliferation
  • The average time from submission to first decision is 43 days, which is moderate for the field.
  • This journal covers Cancer Cells and Metastasis, Mesenchymal stem cell research, MicroRNA in disease regulation. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cell Proliferation Compares
Citation Rate vs Field Avg
+405%
Field avg: 12.77

Compared against 56 journals in the same research areas.

ISSN (Print) 0960-7722
ISSN (Online) 1365-2184
Publisher Wiley
Country United Kingdom
APC / Cost Inquire with Publisher
Review Speed ~43 days to first decision
In-depth profile & metrics

Cell Proliferation is published by Wiley and based in United Kingdom. It publishes on an open-access basis.

In our subject taxonomy, Cell Proliferation is classified under Cancer Cells and Metastasis, Mesenchymal stem cell research, MicroRNA in disease regulation and Pluripotent Stem Cells Research.

For prospective authors, Cell Proliferation returns a first decision in about 43 days (moderate for its field).

Its citation rate has held broadly steady over the last 1 years, from 61.275 (2023) to 64.500 (2024).

Research Areas
Links
Frequently Asked Questions about Cell Proliferation

Cell Proliferation does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 64.500 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Cell Proliferation is an open access journal.

The average time from submission to first decision at Cell Proliferation is approximately 43 days.

Cell Proliferation is published by Wiley.

Cell Proliferation shows strong legitimacy signals: it is indexed in DOAJ. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Cell Proliferation is 0960-7722. Its electronic ISSN (eISSN) is 1365-2184.

Cell Proliferation sits in the Q1 quartile based on its latest impact factor of 64.50, ranked across all journals in our database.
Live Indexing Status
Updated March 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
64.500
2-Year Citation Rate (OpenAlex) · 2024
Historical Trend

The impact factor has remained stable over the last 1 years (from 61.275 to 64.500), reflecting consistent citation performance.

Citation Rate by Year
Year Value Source
2024 64.500 2-Year Mean Citedness (OpenAlex)
2023 61.275 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Journal Metrics
43
Days to Decision

Related Journals in Your Field

Metadata

Last updated: Mar 20, 2026

Updated by: system

Get weekly updates for Cancer Cells and Metastasis journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google